Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Details Dished On Regulatory Pathway US FDA’s Developing For Lawful Hemp In Supplements

May 31 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US FDA Doubts Hemp ‘Derivatives Created From Scratch’ Belong In Lawful Use Pathway

Feb 06 2023

Is US Hemp Policy Heading For Farm Bill, Act III?

Jan 27 2023

CBD Will Be US FDA’s ‘One’ Lawful Hemp Compound, House Appropriators Anticipate

Jul 13 2022

FDA Road To Decision On Expanding CBD Uses Starts With Weighing Impact On Existing And Future Use As Drug

Jun 03 2019

US Hemp Industry Group Rings Alarm With Congress About FDA’s Safety Conclusions

May 31 2023

Bill Steering Hemp In Supplements To NDI Notification Pathway Introduced For Third Time

Mar 17 2023

Additional Topics

International United States US States Cannabidiol CBD Politics FDA Advertising, Marketing & Sales Business Strategies Commercial Compliance Consumer Dietary Supplements Enforcement Ingredients Legislation Lobbying Policy Regulation

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window